[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2426 Introduced in House (IH)]
114th CONGRESS
1st Session
H. R. 2426
To amend the Federal Food, Drug, and Cosmetic Act with respect to
easing regulatory burden with respect to certain class I and class II
devices.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 19, 2015
Mr. Shimkus introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act with respect to
easing regulatory burden with respect to certain class I and class II
devices.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. EASING REGULATORY BURDEN WITH RESPECT TO CERTAIN CLASS I AND
CLASS II DEVICES.
(a) Class I Devices.--Section 510(l) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360(l)) is amended--
(1) by striking ``A report under subsection (k)'' and
inserting ``(1) A report under subsection (k)''; and
(2) by adding at the end the following new paragraph:
``(2) Not later than 120 days after the date of the enactment of
the 21st Century Cures Act, the Secretary shall identify, through
publication in the Federal Register, any type of class I device that
the Secretary determines no longer requires a report under subsection
(k) to provide reasonable assurance of safety and effectiveness. Upon
such publication--
``(A) each type of class I device so identified shall be
exempt from the requirement for a report under subsection (k);
and
``(B) the classification regulation applicable to each such
type of device shall be deemed amended to incorporate such
exemption.''.
(b) Class II Devices.--Section 510(m) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 360(m)) is amended--
(1) by striking paragraph (1) and inserting the following
new paragraph:
``(1) The Secretary shall--
``(A) not later than 60 days after the date of the
enactment of the 21st Century Cures Act--
``(i) publish in the Federal Register a notice that
contains a list of each type of class II device that
the Secretary determines no longer requires a report
under subsection (k) to provide reasonable assurance of
safety and effectiveness; and
``(ii) provide for a period of not less than 60
days for public comment beginning on the date of the
publication of such notice; and
``(B) not later than 180 days after the date of the
enactment of 21st Century Cures Act, publish in the Federal
Register a list representing the Secretary's final
determination with respect to the devices contained in the list
published under subparagraph (A).'';
(2) in paragraph (2)--
(A) by striking ``1 day after the date of
publication of a list under this subsection,'' and
inserting ``1 day after the date of publication of the
final list under paragraph (1)(B),''; and
(B) by striking ``30-day period'' and inserting
``60-day period''; and
(3) by adding at the end the following new paragraph:
``(3) Upon the publication of the final list under paragraph
(1)(B)--
``(A) each type of class II device so listed shall be
exempt from the requirement for a report under subsection (k);
and
``(B) the classification regulation applicable to each such
type of device shall be deemed amended to incorporate such
exemption.''.
<all>